The first annual plenary meeting of the PREDICTION-ADR consortium was held in Utrecht on September 9th and 10th, 2014. Prediction-ADR aims to discover the genetic factors predisposing patients to adverse drug reactions from cardiovascular disease drugs.
The meeting was focused on the planning of recruiting cases and controls for the ACEi induced angioedema and statin induced myopathy. Sequencing harmonisation and protocol for the uniform targeting of exome sequencing to be used for the main study were also discussed.
Learn more from the link below:
https://www.asperbio.com/wp-content/uploads/PREDICTION-ADR_Newsletter_1.pdf